Chief Executive Officer
Robert Berman has served as our Chief Executive Officer since April of 2018. Mr. Berman has over 25 years of experience in a broad variety of areas including healthcare, finance, acquisitions, marketing, compliance, turnarounds, and the development and licensing of emerging technologies. From September 2012 until July 2017, he served as the President, Chief Executive Officer, and a member of the Board of Directors of ITUS Corporation, a Nasdaq listed company that is developing a liquid biopsy technology for early cancer detection. Prior to ITUS, Mr. Berman was the CEO of VIZ Technologies, a start-up company which developed a beverage dispensing cap, and he was the founder of IP Dispute Resolution Corporation, a company focused on intellectual property licensing. From 2000 to March 2007 Mr. Berman was the Chief Operating Officer and General Counsel of Acacia Research Corporation, which became the preeminent, publicly traded company for licensing and enforcing patented technologies. He started his career at the law firm of Blank Rome. Mr. Berman has a B.S. in Entrepreneurial Management from the Wharton School of the University of Pennsylvania and holds a J.D. from the Northwestern University School of Law, where he is an adjunct faculty member.
Chief Financial Officer
Mr. Rankin has more than twenty years of relevant experience helping to shape the operations and financial health of companies across multiple industries. Prior to joining the Company, from November 2015 to December 2017, Mr. Rankin was the Chief Financial Officer of Horsburgh & Scott, a privately held company focused on the design, engineering, manufacturing and repair of heavy duty quality gears and gearboxes. From November 2009 to December 2014, Mr. Rankin was Chief Financial Officer, Chief Operating Officer and Secretary of Process Fab, Inc., a privately held engineering, design and manufacturing firm that provides flight hardware, ground support equipment and tooling to the spaceflight, aerospace and defense markets. Mr. Rankin also served as Vice President of Finance of TBGA LLC, the post-acquisition parent company of Process Fab, Inc., from December 2014 to August 2015. Mr. Rankin holds a Masters of Science degree in Industrial Administration from the Tepper School of Business at Carnegie Mellon University and a Bachelors of Science degree in Mechanical Engineering from Carnegie Mellon University.
Marc Glickman, M.D.
Senior Vice President and Chief Medical Officer
Marc H. Glickman, M.D. has served as our Senior Vice President and Chief Medical Officer since May 2016 and served as member of our board of directors from July 2016 to August 2017. In 1981, Dr. Glickman started a vascular practice in Norfolk, Virginia. He established the first Vein Center in Virginia and also created a dialysis access center. He was employed by Sentara Health Care as director of Vascular Services until he retired in 2014. Dr. Glickman is a board certified vascular surgeon. Dr. Glickman received his Doctor of Medicine from Case Western Reserve, in Cleveland, Ohio and completed his residency at the University of Washington, Seattle. He is board certified in Vascular Surgery and was the past president of the Vascular Society of the Americas. He has served on the advisory boards of Possis Medical, Cohesion Technologies, Thoratec, GraftCath, Inc., TVA medical, Austin, Texas.
Vice President of Regulatory Affairs and Quality Assurance
Ms. Sarner has more than twenty-five years of experience working with a variety of medical device companies from start-ups to industry leaders, as well as six years as a medical device regulator. While in the private sector, Ms. Sarner has worked on 30 products that have received FDA approval and CE mark certification, and as a regulator she has reviewed and granted CE mark certification for more than 50 Class III medical devices. She comes to Hancock Jaffe from a senior position at DEKRA Certification B.V., a European Notified Body where she reviewed design dossiers and conducted quality systems and regulatory audits for medical device companies seeking CE marking. Her prior medical device industry experience includes regulatory strategy, quality assurance, new product development, project management, and clinical marketing in leadership positions at Arbor Surgical Technologies (sold to Medtronic), Edwards Lifesciences, Baxter Healthcare, and Medtronic, primarily on tissue based surgical and percutaneous cardiovascular implants. In her previous roles, Chris has led numerous new and innovative product development projects, including Transcatheter Aortic Valve Implant (TAVI) devices, Modular Aortic Valve devices, and Abdominal Aortic Aneurysm systems, from early feasibility to commercialization. Her technical expertise includes tissue engineering, microbiology, biochemistry, biocompatibility, microbiology and sterilization.
Ms. Sarner has an MBA from Pepperdine University Graziadio School of Business and Management, and a B.S. in Biological Science from the University of California, Irvine.